⌘K

Login Start Free

Home/Filings/4/0001181431-14-007818

4//SEC Filing

Sagent Pharmaceuticals, Inc. 4

Accession 0001181431-14-007818

CIK 0001369786operating

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 9:15 PM ET

Size

6.7 KB

Accession

0001181431-14-007818

Insider Transaction Report

Form 4

Period: 2014-02-18

Sagent Pharmaceuticals, Inc.SGNT

President

Transactions

Award
Stock Option to Buy
2014-02-18+11,968→ 11,968 total
Exercise: $20.16Exp: 2024-02-18→ Common Stock (11,968 underlying)
Award
Common Stock
2014-02-18+6,696→ 6,696 total

Footnotes (1)

[F1]The option vests in four equal installments beginning on February 18, 2015.

Documents

1 file

4
rrd402822.xmlPrimary

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001369786

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 9:15 PM ET
Size: 6.7 KB

View on SEC.gov